A longer-lasting alternative to Botox has been approved by the Food and Drug Administration.
The anti-wrinkle injectable medication is called Daxxify and it was developed by Revance Therapeutics, Inc.
Company officials say Daxxify is the first facial injectable medication to see results typically lasting up to 6 months. They add that this means wrinkles can be prevented and managed in as little as two appointments per year.
Revance officials said data from a recent phase 3 clinical trial on the treatment of eyebrow wrinkles suggest Daxxify is well-tolerated and has high levels of patient satisfaction. The clinical trials included 2,700 participants and approximately 4,200 treatments. Among the reported results:
- Results in as early as one day after treatment (more typically seen within two days)
- 98% of people showed no signs of wrinkle development at 4-week follow-up post-treatment
- 88% of people showed clinically significant wrinkle improvement at a 4-week follow-up
Effects from other neuromodulators or neurotoxins such as Botox, Xeomin, and Jeuveau typically last about three months, according to the American Society for Dermatologic Surgery (ASDS). Experts say there are pros and cons to a longer-lasting facial injection.